Position paper: Breast cancer screening, diagnosis, and treatment in Denmark

Acta Oncologica

Volumn 53, Issue 4, 2014, Pages 433-444

  Christiansen, Peer ^a   Vejborg, Ilse ^b   Kroman, Niels ^c   Holten, Iben ^d   Garne, Jens Peter ^e   Vedsted, Peter ^f   Moller, Susanne ^c   Lynge, Elsebeth ^g  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c Rigshospitalet   (Denmark)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f Danish Research Centre for Cancer Diagnosis in Primary Care CaP   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; DENMARK; DIAGNOSTIC ERROR; HEALTH PROGRAM; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; BREAST NEOPLASMS; FEMALE; MASS SCREENING;

BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING;

EID: 84896984420     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.874573     Document Type: Review

References (41)

1. NORDCAN database [Internet]. [cited 2012 Mar 8]. Available from: http//www-dep.iarc.fr/nordcan.htm.
2. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 2011; 377: 127-38.
3. Mouridsen HT, Bjerre KD, Christiansen P, Jensen M-B, M ø ller S. Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry. Acta Oncol 2008; 47: 525-36.
4. Christensen LH, Engholm G, Ceberg J, Hein S, Perfekt R, Tange UB, et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? - a population-based study. Eur J Cancer 2004; 40: 1233-43.
5. Jensen AR, Garne JP, Storm HH, Engholm G, Möller T, Overgaard J. Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden? Acta Oncol 2004; 43: 719-26.
6. Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: A population-based study. Br J Cancer 2013; 108: 1195-208.
7. Jensen A, Olsen AH, von Euler-Chelpin M, Helle Njor S, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer 2005; 113: 464-70.
8. Domingo L, Jacobsen KK, von Euler-Chelpin M, Vejborg I, Schwartz W, Sala M, et al. Seventeen-years overview of breast cancer inside and outside screening in Denmark. Acta Oncol 2013; 52: 48-56.
9. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition - summary document. Ann Oncol 2008; 19: 614-22.
10. Vejborg I, Mikkelsen EM, Schwartz W, Bak M, Lernevall A, Borg Mogensen N, et al. [Danish Quality Database for Mammography Screening]. Ugeskr Laeger 2012; 174: 2533.
11. IARC handbooks of cancer prevention. Vol. 7: Breast cancer screening. Lyon: IARC Press; 2002.
12. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 727-37, W237-42.
13. Anonymous. The benefits and harms of breast cancer screening: An independent review. Lancet 2012; 380: 1778-86.
14. Sarkeala T, Heinävaara S, Anttila A. Breast cancer mortality with varying invitational policies in organised mammogra-phy. Br J Cancer 2008; 98: 641-5.
15. Jonsson H, Nyström L, Törnberg S, Lundgren B, Lenner P. Service screening with mammography. Long-term effects on breast cancer mortality in the county of Gävleborg, Sweden. Breast 2003; 12: 183-93.
16. Jonsson H, Bordás P, Wallin H, Nyström L, Lenner P. Service screening with mammography in Northern Sweden: Effects on breast cancer mortality - an update. J Med Screen 2007; 14: 87-93.
17. Kalager M, Zelen M, Langmark F, Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010; 363: 1203-10.
18. Lynge E, Braaten T, Njor SH, Olsen AH, Kumle M, Waaseth M, et al. Mammography activity in Norway 1983 to 2008. Acta Oncol 2011; 50: 1062-7.
19. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: Cohort study. Br Med J 2005; 330: 220.
20. Jorgensen KJ, Zahl P-H, Gotzsche PC. Breast cancer mortality in organised mammography screening in Denmark: Comparative study. Br Med J 2010; 340: c1241.
21. Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E. Breast cancer incidence after the introduction of mammog-raphy screening: What should be expected? Cancer 2006; 106: 1883-90.
22. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmömammographic screening trial: Follow-up study. Br Med J 2006; 332: 689-92.
23. Miller AB, T o T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002; 137: 305-12.
24. Miller AB, T o T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-9.
25. Njor SH, Garne JP, Lynge E. Over-diagnosis estimate from The Independent UK Panel on Breast Cancer Screening is based on unsuitable data. J Med Screen 2013; 20: 104-5.
26. De Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting over- diagnosis estimates in population-based mammography screening. Epidemiol Rev 2011; 33: 111-21.
27. Waller M, Moss S, Watson J, Møller H. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev 2007; 16: 2257-61.
28. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, et al. Absolute numbers of lives saved and over-diagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010; 17: 25-30.
29. Paci E, Miccinesi G, Puliti D, Baldazzi P, De Lisi V, Falcini F, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res 2006; 8: R68.
30. Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009; 45: 3166-71.
31. Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW. Over-diagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006; 12: 338-42.
32. Jørgensen KJ, Zahl P-H, Gøtzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health 2009; 9: 36.
33. Njor SH, Olsen A. H, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E: Overdiagnosis in screening mammography in Denmark: Population based cohort study. Br Med J 2013; 346: f1064.
34. Laenkholm A-V, Jensen M-B, Kroman N, Rank F. Breast cancer in situ. From pre-malignant lesion of uncertain significance to well-defined non-invasive malignant lesion. The Danish Breast Cancer Cooperative Group Register 1977-2007 revisited. Acta Oncol 2008; 47: 765-71.
35. Paci E. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012; 19(Suppl 1): 5-13.
36. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367: 1998-2005.
37. Zahl P-H, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008; 168: 2311-6.
38. Richards C. Spontaneous regression of breast cancer (editor' s correspondence). Arch Intern Med 2011; 169: 996.
39. Larsen SU, Rose C. Spontaneous remission of breast cancer. A literature review. Ugeskr Laeger 1999; 161: 4001-4.
40. Christensen LH, Andersson M, Storm HH. [Untreated breast cancer in Denmark 1978-1995]. Ugeskr Laeger 2001; 163: 2774-8.
41. Zahl P-H, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: A cohort study. Lancet Oncol 2011; 12: 1118-24.